Clinical Trials Browser

Enrolling by invitation × Interventional × Chemoradiotherapy × Clear all

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Phase 2 Enrolling by invitation

Gastrointestinal

Pancreatic Cancer Non-resectable

NCT06048926 2023-09-21

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

Phase NA Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma